Skip to main content
TLSI
NASDAQ Industrial Applications And Services

TriSalus Q3 Revenue $12.9M; 2026 Guidance Cut to $46-48M as CMS Boosts PEDD Reimbursement

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$3.001
Mkt Cap
$198.27M
52W Low
$2.2
52W High
$7.95
52W Position info
36% above low
Off High info
62% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

TLSI sits 36% above its 52-week low of $2.2.

Summary

TriSalus grew Q3 revenue 11.3% to $12.9 million but trimmed 2026 guidance to $46-48 million as its expanded sales force ramps slowly. CMS finalized 2027 reimbursement changes that roughly double payment for its main procedure code.


Key Events · Earnings and Guidance · TLSI

  • Q3 Revenue Up 11.3% to $12.9M

    TriNav revenue was $12.9 million for the quarter ended September 30, 2026, versus $11.6 million a year earlier, with gross margin rising to 86.2% from 83.5% on lower cost per unit.

  • 2026 Guidance Cut to $46-48M

    Full-year 2026 revenue guidance was revised to $46 million to $48 million, representing roughly 2% to 6% growth over 2025, after the expanded commercial team ramped slower than anticipated.

  • CMS Raises PEDD Reimbursement for 2027

    CMS finalized reassignment of HCPCS C8004 to APC 5194, lifting the national Medicare rate from about $11,794 to about $20,910 per procedure, and set a national payment of about $13,800 for new office-based-lab code G0577 — both effective January 1, 2027.

  • Losses Narrow; $41.1M Cash Left

    Operating loss was $7.7 million versus $9.0 million a year ago and adjusted EBITDA loss was $4.7 million versus $5.4 million; cash and equivalents totaled $41.1 million at September 30, 2026.


Analysis · TLSI · Industrial Applications And Services

The near-term numbers disappoint, but the 2027 reimbursement setup is what matters here. Revenue grew 11.3% to $12.9 million and gross margin improved to 86.2%, yet management cut full-year 2026 guidance to $46-48 million — only 2% to 6% growth — and conceded the doubled sales force is ramping slower than planned. Against that, CMS finalized two 2027 payment rules that materially raise reimbursement for the company's core procedures: C8004 jumps from about $11,794 to about $20,910 per case, and new code G0577 pays about $13,800 per office-based lab procedure. Cash of $41.1 million against a $7.7 million quarterly operating loss leaves roughly five quarters of runway before another raise.

How filings like this one have moved

In the 30 days to Nov 10, 2026, 36.4% of the 3168 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TLSI was trading at $3.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $198.3M. The 52-week trading range was $2.20 to $7.95. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TLSI - Latest Insights

TLSI
Nov 10, 2026, 8:08 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.00
Real-time Price: $3.00 info
Change: -$0.0005 (-0.02%) info
Market Cap: $198.27M info
TLSI
Nov 10, 2026, 8:05 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $3.22
Real-time Price: $3.00 info
Change: -$0.220 (-7%) info
Market Cap: $198.27M info
TLSI
Sep 22, 2026, 4:15 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $4.93
Real-time Price: $3.00 info
Change: -$1.93 (-39%) info
Market Cap: $198.27M info
TLSI
May 18, 2026, 4:42 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $2.97
Real-time Price: $3.00 info
Change: +$0.030 (+1%) info
Market Cap: $198.27M info
TLSI
May 12, 2026, 4:08 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.50
Real-time Price: $3.00 info
Change: -$1.50 (-33%) info
Market Cap: $198.27M info